Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 384421 - 384440 out of 498428 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Saudi Arabia | (L01DB03) epirubicin | Epirubicin “Ebewe” 50mg/25ml | 1 Vial, 25ml, 2 mg/ml, Intravenous use, Concentrate for solution for infusion, 2mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
Saudi Arabia | (L01DB03) epirubicin | FARMARUBICIN 10MG/5ML INJECTION | 1 Vial, 2 mg/ml, Intravenous use, Solution for injection, 2mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLTD / PFIZERPERTHPTYLIMITED |
Saudi Arabia | (L01DB03) epirubicin | FARMARUBICIN 50MG/25ML VIAL | 1 Vial, 2 mg/ml, Intravenous use, Solution for injection, 2mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLTD / PFIZERPERTHPTYLIMITED |
Saudi Arabia | (L01DB07) mitoxantrone | MITOXANTRON EBEWE 2MG-1ML SOL. FOR INFU | 1 Vial, 10ml, 2 mg/ml, Intravenous use, Solution, 2mg/ml , Vial, Solution | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
Saudi Arabia | (L01DC01) bleomycin | Bleoez | 1 Vial, 15 U, Intravenous, Intramuscular, Subcutaneous, powder for solution for injection, 15U , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | KoreaUnitedPharm.Inc / KoreaUnitedPharm.Inc |
Saudi Arabia | (L01DC01) bleomycin | Bleomycin Venus | 1 Vial, 15 USP Units, Intramuscular and intravenous use, Powder for solution for injection/infusion, 15USP Units , Vial, Powder for solution for injection/infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | VENUSREMEDIESLIMITED / VENUSREMEDIESLIMITED |
Saudi Arabia | (L01EA02) dasatinib (adm: O) | SPRYCEL 20MG F.C. TABLETS | 60 Bottle, 20 mg, Oral use, Film-coated tablet, 20mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBB / AstraZenecaPharmaceuticalsLP |
Saudi Arabia | (L01EA02) dasatinib (adm: O) | SPRYCEL 50MG F.C. TABLETS | 60 Bottle, 50 mg, Oral use, Film-coated tablet, 50mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBB / AstraZenecaPharmaceuticalsLP |
Saudi Arabia | (L01EA02) dasatinib (adm: O) | SPRYCEL 70MG F.C. TABLETS | 60 Bottle, 70 mg, Oral use, Film-coated tablet, 70mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBB / AstraZenecaPharmaceuticalsLP |
Saudi Arabia | (L01EA03) nilotinib (adm: O) | TASIGNA 150MG CAPSULES | 112 Blister, 150 mg, Oral use, Capsule, 150mg , Blister, Capsule | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NOVARTIS / NOVARTIS |
Saudi Arabia | (L01EA06) asciminib (adm: O) | Scemblix | 60 Bottle, 20 mg, Oral use, Film-coated tablet, 20mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited / NOVARTISPharmaSteinAG |
Saudi Arabia | (L01EA06) asciminib (adm: O) | Scemblix | 60 Bottle, 40 mg, Oral use, Film-coated tablet, 40mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited / NOVARTISPharmaSteinAG |
Saudi Arabia | (L01EB02) erlotinib (adm: O) | Erlotinib EPC | 30 Blister, 100 mg, Oral use, Film-coated tablet, 100mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | EasternPharmaCo(EPC) / RelianceLifeSciencesPvt.Ltd |
Saudi Arabia | (L01EB02) erlotinib (adm: O) | Erlotinib SPC | 30 Blister, 100 mg, Oral use, Film-coated tablet, 100mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | SUDAIRPHARMACOMPANY / CiplaLimited |
Saudi Arabia | (L01EB02) erlotinib (adm: O) | Erloz | 30 Blister, 100 mg, Oral use, Film-coated tablet, 100mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | SaudiAmarox / HeteroLabsLimitedUnit–V |
Saudi Arabia | (L01EB02) erlotinib (adm: O) | Tyrox | 30 Blister, 100 mg, Oral use, Film-coated tablet, 100mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | MSPharmaSaudi(MSPS) / REMEDICA |
Saudi Arabia | (L01EB02) erlotinib (adm: O) | TARCEVA 150 mg film-coated tablet | 30 Blister, 150 mg, Oral use, Film-coated tablet, 150mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms | ROCHE / DelpharmMilano,S.r.l. |
Saudi Arabia | (L01EB02) erlotinib (adm: O) | Tyrox | 30 Blister, 25 mg, Oral use, Film-coated tablet, 25mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | MSPharmaSaudi(MSPS) / REMEDICA |
Saudi Arabia | (L01EB03) afatinib (adm: O) | GIOTRIF 30 mg film-coated tablet | 28 Blister, 30 mg, Oral use, Film-coated tablet, 30mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BOEHRINGERINGELHEIM / BOEHRINGERINGELHEIM |
Saudi Arabia | (L01EB03) afatinib (adm: O) | GIOTRIF 40 mg film-coated tablet | 28 Blister, 40 mg, Oral use, Film-coated tablet, 40mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BOEHRINGERINGELHEIM / BOEHRINGERINGELHEIM |